Patents by Inventor Jeffrey A. Steward
Jeffrey A. Steward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7943916Abstract: The invention relates generally to methods of monitoring and controlling the processing of blood and blood samples, particularly the separation of blood and blood samples into its components with a two-dimensional optical measurement and control device. The method may comprise the steps of providing a blood processing system comprising a density centrifuge blood processing system and an elutriation blood processing system; filling the elutriation blood processing system with a desired component; measuring a cellular flux of cells entering the elutriation blood processing system with a two-dimensional optical control system; and flushing the elutriation blood processing system.Type: GrantFiled: September 17, 2009Date of Patent: May 17, 2011Assignee: CaridianBCT, Inc.Inventors: Lee F. Carter, Jeremy P. Kolenbrander, James R. Ladtkow, Joseph A. Scibona, Jeffrey A. Steward, Chris Fletcher
-
Patent number: 7906771Abstract: The invention relates generally to methods of monitoring and controlling the processing of blood and blood samples, particularly the separation of blood and blood samples into its components. In one aspect, the invention relates to optical methods for measuring two-dimensional distributions of transmitted light intensities, scattered light intensities or both from a separation chamber of a density centrifuge. The method may include performing first and second measurements of an operating condition; analyzing the first and second measurements using a predictive data analysis algorithm; comparing the predicted operating condition to a desired operating condition; and adjusting at least one setting.Type: GrantFiled: September 17, 2009Date of Patent: March 15, 2011Assignee: CaridianBCT, Inc.Inventors: Lee F. Carter, Jeremy P. Kolenbrander, James R. Ladtkow, Joseph A. Scibona, Jeffrey A. Steward, Chris Fletcher
-
Patent number: 7901359Abstract: A method and apparatus for improving blood flow to an ischemic region (e.g., myocardial ischemia) a patient is provided. An ultrasonic transducer is positioned proximate to the ischemic region. Ultrasonic energy is applied at a frequency at or above 1 MHz to create one or more thermal lesions in the ischemic region of the myocardium. The thermal lesions can have a gradient of sizes. The ultrasound transducer can have a curved shape so that ultrasound energy emitted by the transducer converges to a site within the myocardium, to create a thermal lesion without injuring the epicardium or endocardium.Type: GrantFiled: December 6, 2005Date of Patent: March 8, 2011Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Evgenia Mandrusov, Jeffrey Steward, Marshall Sherman
-
Publication number: 20100025336Abstract: The invention relates generally to methods of monitoring and controlling the processing of blood and blood samples, particularly the separation of blood and blood samples into its components. In one aspect, the invention relates to optical methods for measuring two-dimensional distributions of transmitted light intensities, scattered light intensities or both from a separation chamber of a density centrifuge. The method may include performing first and second measurements of an operating condition; analyzing the first and second measurements using a predictive data analysis algorithm; comparing the predicted operating condition to a desired operating condition; and adjusting at least one setting.Type: ApplicationFiled: September 17, 2009Publication date: February 4, 2010Applicant: CARIDIANBCT, INC.Inventors: Lee F. CARTER, Jeremy P. KOLENBRANDER, James R. LADTKOW, Joseph A. SCIBONA, Jeffrey A. STEWARD, Chris FLETCHER
-
Publication number: 20100012592Abstract: The invention relates generally to methods of monitoring and controlling the processing of blood and blood samples, particularly the separation of blood and blood samples into its components with a two-dimensional optical measurement and control device. The method may comprise the steps of providing a blood processing system comprising a density centrifuge blood processing system and an elutriation blood processing system; filling the elutriation blood processing system with a desired component; measuring a cellular flux of cells entering the elutriation blood processing system with a two-dimensional optical control system; and flushing the elutriation blood processing system.Type: ApplicationFiled: September 17, 2009Publication date: January 21, 2010Applicant: CARIDIANBCT, INC.Inventors: Lee F. CARTER, Jeremy P. KOLENBRANDER, James R. LADTKOW, Joseph A. SCIBONA, Jeffrey A. STEWARD, Chris FLETCHER
-
Patent number: 7605388Abstract: The invention relates to an optical cell for a separation chamber of a density centrifuge blood processing system for separating fluid components comprising an extraction chamber having a first external optical surface for transmitting at least a portion of an incident optical beam; and an extraction port having an axial bore for passing fluid components and a first external optical surface for transmitting at least a portion of the incident optical beam; wherein said first external optical surface of said extraction chamber and said first external optical surface of said extraction port are both positioned within the depth of field of a light collection element.Type: GrantFiled: July 7, 2008Date of Patent: October 20, 2009Assignee: CaridianBCT, Inc.Inventors: Lee F. Carter, Jeremy P. Kolenbrander, James R. Ladtkow, Joseph A. Scibona, Jeffrey A. Steward, Chris Fletcher
-
Patent number: 7556611Abstract: An extracorporeal blood processing system having a centrifugal rotor, a control system, a plurality of peristaltic pumps, and a removable tubing circuit wherein blood components can be processed. A pump-balancing process, implemented by the control system, causes selected pumps to fill and empty a reservoir in the tubing circuit. Ratios of displaced volume per pump revolution or other pumping action can be used by the control system to increase the effectiveness and efficiency of the donation process. The pump-balancing process may be performed during priming or set-up of the blood processing system or during an actual donation.Type: GrantFiled: November 28, 2006Date of Patent: July 7, 2009Assignee: CaridianBCT, Inc.Inventors: Jeremy Kolenbrander, William Palsulich, James Ladtkow, Dave Tyler, Jeffrey A. Steward, Dave Gibbons, John R. Lindner
-
Publication number: 20080283781Abstract: The invention relates to an optical cell for a separation chamber of a density centrifuge blood processing system for separating fluid components comprising an extraction chamber having a first external optical surface for transmitting at least a portion of an incident optical beam; and an extraction port having an axial bore for passing fluid components and a first external optical surface for transmitting at least a portion of the incident optical beam; wherein said first external optical surface of said extraction chamber and said first external optical surface of said extraction port are both positioned within the depth of field of a light collection element.Type: ApplicationFiled: July 7, 2008Publication date: November 20, 2008Applicant: GAMBRO BCT, INC.Inventors: Lee F. CARTER, Jeremy P. KOLENBRANDER, James R. LADTKOW, Joseph A. SCIBONA, Jeffrey A. STEWARD, Chris FLETCHER
-
Patent number: 7422693Abstract: The invention relates generally to methods of monitoring and controlling the processing of blood and blood samples, particularly the separation of blood and blood samples into its components. In one aspect, the invention relates to optical methods, devices and device components for measuring two-dimensional distributions of transmitted light intensities, scattered light intensities or both from a separation chamber of a density centrifuge. In embodiment, two-dimensional distributions of transmitted light intensities, scattered light intensities or both measured by the methods of the present invention comprise images of a separation chamber or component thereof, such as an optical cell of a separation chamber. In another aspect, the present invention relates to multifunctional monitoring and control systems for blood processing, particularly blood processing via density centrifugation.Type: GrantFiled: July 1, 2004Date of Patent: September 9, 2008Assignee: Caridianbct, Inc.Inventors: Lee F. Carter, Jeremy P. Kolenbrander, James R. Ladtkow, Joseph A. Scibona, Jeffrey A. Steward, Chris Fletcher
-
Publication number: 20070243990Abstract: An extracorporeal blood processing system having a centrifugal rotor, a control system, a plurality of peristaltic pumps, and a removable tubing circuit wherein blood components can be processed. A pump-balancing process, implemented by the control system, causes selected pumps to fill and empty a reservoir in the tubing circuit. Ratios of displaced volume per pump revolution or other pumping action can be used by the control system to increase the effectiveness and efficiency of the donation process. The pump-balancing process may be performed during priming or set-up of the blood processing system or during an actual donation.Type: ApplicationFiled: November 28, 2006Publication date: October 18, 2007Applicant: GAMBRO, INC.Inventors: Jeremy KOLENBRANDER, William PALSULICH, Jeffrey A. STEWARD, Dave GIBBONS, John R. LINDNER, James LADTKOW, Dave TYLER
-
Publication number: 20070135714Abstract: The invention relates to an apparatus and method for imaging and mapping various structures located at a target area within a patient's lumen using conventional IVUS technology. The mapped images are used to accurately determine and control the location of the device within the lumen relative to the target area and/or target site. Once the drug delivery device is properly positioned within the lumen, additional ultrasonic images are generated and used to control the position and depth of penetration of a retractable needle of the device. Needle position can be precisely determined, both in relationship to the device as well as the target site for drug delivery. This allows accurate delivery of drug to the target site and, thus, enhanced treatment capabilities.Type: ApplicationFiled: February 2, 2007Publication date: June 14, 2007Inventors: Jeffrey Steward, Mina Chow
-
Publication number: 20070093745Abstract: A medical Assembly is used to delivery a therapeutic substance to a treatment area. The medical assembly comprises a catheter having a distal end and a proximal end, a transducer supported by at least a portion of the distal end of the catheter assembly, and a delivery lumen mounted on the catheter for delivery of a therapeutic substance. Support for the transducer is provided at a preselected number of anchoring points, wherein an inner surface of the transducer is positioned at a preselected distance from an outer surface of the catheter. The preselected distance defines a gap that is occupied by a low density material such as a gas which reflects acoustic pressure waves directed toward the gap by a transducer when a voltage is applied to the transducer. The reflected pressure wave increases the energy in the system, enhancing transport of therapeutic substances from the delivery lumen to the surrounding tissues and/or cells to be treated.Type: ApplicationFiled: December 8, 2006Publication date: April 26, 2007Inventors: Jeffrey Steward, Brandon Gosiengfiao
-
Publication number: 20070088246Abstract: A medical Assembly is used to delivery a therapeutic substance to a treatment area. The medical assembly comprises a catheter having a distal end and a proximal end, a transducer supported by at least a portion of the distal end of the catheter assembly, and a delivery lumen mounted on the catheter for delivery of a therapeutic substance. Support for the transducer is provided at a preselected number of anchoring points, wherein an inner surface of the transducer is positioned at a preselected distance from an outer surface of the catheter. The preselected distance defines a gap that is occupied by a low density material such as a gas which reflects acoustic pressure waves directed toward the gap by a transducer when a voltage is applied to the transducer. The reflected pressure wave increases the energy in the system, enhancing transport of therapeutic substances from the delivery lumen to the surrounding tissues and/or cells to be treated.Type: ApplicationFiled: December 8, 2006Publication date: April 19, 2007Inventors: Jeffrey Steward, Brandon Gosiengfiao
-
Publication number: 20070083149Abstract: A medical Assembly is used to delivery a therapeutic substance to a treatment area. The medical assembly comprises a catheter having a distal end and a proximal end, a transducer supported by at least a portion of the distal end of the catheter assembly, and a delivery lumen mounted on the catheter for delivery of a therapeutic substance. Support for the transducer is provided at a preselected number of anchoring points, wherein an inner surface of the transducer is positioned at a preselected distance from an outer surface of the catheter. The preselected distance defines a gap that is occupied by a low density material such as a gas which reflects acoustic pressure waves directed toward the gap by a transducer when a voltage is applied to the transducer. The reflected pressure wave increases the energy in the system, enhancing transport of therapeutic substances from the delivery lumen to the surrounding tissues and/or cells to be treated.Type: ApplicationFiled: December 8, 2006Publication date: April 12, 2007Inventors: Jeffrey Steward, Brandon Gosiengfiao
-
Patent number: 7179249Abstract: The invention relates to an apparatus and method for imaging and mapping various structures located at a target area within a patient's lumen using conventional IVUS technology. The mapped images are used to accurately determine and control the location of the device within the lumen relative to the target area and/or target site. Once the drug delivery device is properly positioned within the lumen, additional ultrasonic images are generated and used to control the position and depth of penetration of a retractable needle of the device. Needle position can be precisely determined, both in relationship to the device as well as the target site for drug delivery. This allows accurate delivery of drug to the target site and, thus, enhanced treatment capabilities.Type: GrantFiled: March 17, 2003Date of Patent: February 20, 2007Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Jeffrey Steward, Mina Chow
-
Patent number: 7166098Abstract: A medical assembly is used to deliver a therapeutic substance to a treatment area. The medical assembly comprises a catheter having a distal end and a proximal end, a transducer supported by at least a portion of the distal end of the catheter assembly, and a delivery lumen mounted on the catheter for delivery of a therapeutic substance. Support for the transducer is provided at a preselected number of anchoring points, wherein an inner surface of the transducer is positioned at a preselected distance from an outer surface of the catheter. The preselected distance defines a gap that is occupied by a low density material such as a gas which reflects acoustic pressure waves directed toward the gap by a transducer when a voltage is applied to the transducer. The reflected pressure wave increases the energy in the system, enhancing transport of therapeutic substances from the delivery lumen to the surrounding tissues and/or cells to be treated.Type: GrantFiled: December 30, 1999Date of Patent: January 23, 2007Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Jeffrey A. Steward, Brandon Gosiengfiao
-
Publication number: 20060100554Abstract: A method and apparatus for improving blood flow to an ischemic region (e.g., myocardial ischemia) a patient is provided. An ultrasonic transducer is positioned proximate to the ischemic region. Ultrasonic energy is applied at a frequency at or above 1 MHz to create one or more thermal lesions in the ischemic region of the myocardium. The thermal lesions can have a gradient of sizes. The ultrasound transducer can have a curved shape so that ultrasound energy emitted by the transducer converges to a site within the myocardium, to create a thermal lesion without injuring the epicardium or endocardium.Type: ApplicationFiled: December 6, 2005Publication date: May 11, 2006Applicant: Advanced Cardiovascular Systems, Inc.Inventors: Evgenia Mandrusov, Jeffrey Steward, Marshall Sherman
-
Patent number: 7001336Abstract: A method and apparatus for improving blood flow to an ischemic region (e.g., myocardial ischemia) a patient is provided. An ultrasonic transducer is positioned proximate to the ischemic region. Ultrasonic energy is applied at a frequency at or above 1 MHz to create one or more thermal lesions in the ischemic region of the myocardium. The thermal lesions can have a gradient of sizes. The ultrasound transducer can have a curved shape so that ultrasound energy emitted by the transducer converges to a site within the myocardium, to create a thermal lesion without injuring the epicardium or endocardium.Type: GrantFiled: April 1, 2004Date of Patent: February 21, 2006Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Evgenia Mandrusov, Jeffrey Steward, Marshall Sherman
-
Publication number: 20050051466Abstract: The invention relates generally to methods of monitoring and controlling the processing of blood and blood samples, particularly the separation of blood and blood samples into its components. In one aspect, the invention relates to optical methods, devices and device components for measuring two-dimensional distributions of transmitted light intensities, scattered light intensities or both from a separation chamber of a density centrifuge. In embodiment, two-dimensional distributions of transmitted light intensities, scattered light intensities or both measured by the methods of the present invention comprise images of a separation chamber or component thereof, such as an optical cell of a separation chamber. In another aspect, the present invention relates to multifunctional monitoring and control systems for blood processing, particularly blood processing via density centrifugation.Type: ApplicationFiled: July 1, 2004Publication date: March 10, 2005Inventors: Lee Carter, Jeremy Kolenbrander, James Ladtkow, Joseph Scibona, Jeffrey Steward, Chris Fletcher
-
Patent number: 6860946Abstract: Methods of coating an implantable device and a system for performing such methods are disclosed. An embodiment of the method includes applying a coating substance to the surface of an implantable device, and rotating the implantable device in a centrifuge. The method can uniformly coat the implantable device with the coating substance and to remove unwanted accumulations of coating substance entrained between struts or crevices in the implantable device body. This system is applicable to methods for coating intraluminal stents, synthetic grafts, and stent coverings with therapeutic compositions comprising therapeutic agents mixed with a polymeric matrix and a solvent.Type: GrantFiled: March 5, 2003Date of Patent: March 1, 2005Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Syed F. A. Hossainy, Jeffrey Steward